MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, TARS made $118,697,000 in revenue. -$12,335,000 in net income. Net profit margin of -10.39%.

Income Overview

Revenue
$118,697,000
Net Income
-$12,335,000
Net Profit Margin
-10.39%
EPS
-$0.3
Unit: Dollar
Revenue Breakdown
    • Product

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Total revenues
118,697,000 102,660,000 78,335,000 45,564,000
Selling, general and administrative
--84,995,000 59,327,500
Research and development
--14,409,000 14,469,500
Cost of sales
--5,211,000 3,290,000
Total operating expenses
133,226,000 124,844,000 104,615,000 78,063,500
Loss from operations before other income (expense)
-14,529,000 -22,184,000 -26,280,000 -31,052,500
Interest income
4,114,000 4,229,000 3,454,000 3,382,000
Interest expense
2,268,000 2,240,000 2,213,000 1,647,500
Realized/unrealized (loss) gain on equity investments
----195,000
Change in fair value of equity warrants issued by licensee
----50,250
Loss on debt extinguishment
0 0 -0
Other income (expense), net
98,000 -145,000 -81,000 141,250
Total other income (expense), net
1,944,000 1,844,000 1,160,000 1,630,500
Loss before income taxes
----28,888,500
Benefit from income taxes
---0
Net loss
-12,585,000 -20,340,000 -25,120,000 -29,422,000
Unrealized gain (loss) on marketable securities and cash equivalents
250,000 -46,000 -94,000 -114,000
Comprehensive loss
-12,335,000 -20,386,000 -25,214,000 -29,536,000
Net loss per share - basic (usd per share)
-0.3 -0.48 -0.64 -0.79
Net loss per share - diluted (usd per share)
-0.3 -0.48 -0.64 -0.79
Weighted-average shares outstanding - diluted (in shares)
42,607,717 42,360,452 39,345,359 -19,300,331.5
Weighted-average shares outstanding, basic (in shares)
42,607,717 42,360,452 39,345,359 -19,300,331.5
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$12,335,000 Unrealized gain (loss) onmarketable securities and...$250,000 Other income(expense), net$98,000 Interest income$4,114,000 Net loss-$12,585,000 Total other income(expense), net$1,944,000 Product$118,697,000 Interest expense$2,268,000 Loss from operationsbefore other income...-$14,529,000 Total revenues$118,697,000 Total operatingexpenses$133,226,000

Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals, Inc. (TARS)